Tema ETFs’s BridgeBio Oncology BBOT Stock Holding History

Tema ETFs’s Portfolio BBOT Stock Details BBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$409K	Buy	99,750 +6,411	+7%	+$49.8K	0.02%	451
2026 Q2	$711K	Buy	93,339 +11,167	+14%	+$93.2K	0.02%	352
2026 Q1	$735K	Buy	+82,172	New	+$882K	0.05%	289

Other funds holding BBOT

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Tema ETFs's BBOT Position: Q3 2026 in Review

Tema ETFs increased its BridgeBio Oncology (BBOT) stake by 6.9% in Q3 2026, buying an estimated $49.8K and bringing the position to 99,750 shares worth $409K. The position accounts for 0.02% of the portfolio, ranked #451.

Tema ETFs first reported a position in BBOT in Q1 2026 and has held it in 3 quarters since. The position peaked at $735K in Q1 2026. 4 funds tracked by Wall St. Rank hold BBOT as of Q3 2026.

Tema ETFs held 99,750 shares of BridgeBio Oncology worth $409K as of Q3 2026.
Tema ETFs bought 6,411 BridgeBio Oncology shares in Q3 2026, an estimated $49.8K.
BridgeBio Oncology made up 0.02% of Tema ETFs's portfolio in Q3 2026, its #451 holding.
Tema ETFs first reported a position in BridgeBio Oncology in Q1 2026 and has held it in 3 quarters since.
Tema ETFs's BridgeBio Oncology position peaked at $735K in Q1 2026.
4 funds tracked by Wall St. Rank held BridgeBio Oncology as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.